Legal Representation
Attorney
John Pickerill
USPTO Deadlines
Next Deadline
1876 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250304)
Due Date
March 04, 2031
Grace Period Ends
September 04, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 4, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 4, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Feb 10, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Feb 10, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jan 15, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Oct 30, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jan 15, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 30, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Apr 12, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 11, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 11, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Apr 11, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 25, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 23, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 23, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 23, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 2, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 7, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 7, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 15, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 27, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 18, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 6, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 5, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Biochemical and chemical preparations for medical use, namely, chemical reagents for medical purposes and excipients in a liquid formulation for oral administration; biological preparations for medical use for the treatment of neurological and psychiatric diseases, inflammatory diseases, HIV/AIDS, spinal muscular atrophy, systemic juvenile idiopathic arthritis, polycythaemia vera, essential thrombocythemia, leukemias, myelomas, myelofibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy and other forms of muscular dystrophy; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders; pharmaceutical products for the treatment of genetic disorders
First Use Anywhere:
Jul 25, 2024
First Use in Commerce:
Jul 25, 2024
Additional Information
Translation
The wording "DUVYZAT" has no meaning in a foreign language.
Classification
International Classes
005